Sources
Morrison AS. The effects of early treatment, lead time and length bias on the mortality experienced by cases detected by screening. Int J Epidemiol. 1982;11(3):261-7.
Welch HG, Woloshin S, Schwartz LM, Gordis L, Gotzsche PC, Harris R, et al. Overstating the evidence for lung cancer screening: the International Early Lung Cancer Action Program (I-ELCAP) study. Arch Intern Med. 2007;167(21):2289-95.
Badgwell BD, Giordano SH, Duan ZZ, Fang S, Bedrosian I, Kuerer HM, et al. Mammography Before Diagnosis Among Women Age 80 Years and Older With Breast Cancer. Journal of Clinical Oncology. 2008;26(15):2482-8.
Berry DA, Baines CJ, Baum M, Dickersin K, Fletcher SW, Gøtzsche PC, et al. Flawed Inferences About Screening Mammography’s Benefit Based on Observational Data. Journal of Clinical Oncology. 2009;27(4):639-40.
Wegwarth O, Schwartz LM, Woloshin S, Gaissmaier W, Gigerenzer G. Do Physicians Understand Cancer Screening Statistics? A National Survey of Primary Care Physicians in the United States. Ann Intern Med. 2012;156(5):340-U152.
Jenny MA, Keller N, Gigerenzer G. Assessing minimal medical statistical literacy using the Quick Risk Test: a prospective observational study in Germany. BMJ Open 2018;8:e020847.
Duffy SW, Nagtegaal ID, Wallis M, Cafferty FH, Houssami N, Warwick J, et al. Correcting for lead time and length bias in estimating the effect of screen detection on cancer survival. Am J Epidemiol. 2008;168(1):98-104.
These sources are retrieved dynamically from PubMed
View more →